12.33MMarket Cap-693P/E (TTM)
1.5000High1.1600Low854.28KVolume1.1600Open1.0900Pre Close1.12MTurnover11.02%Turnover RatioLossP/E (Static)8.74MShares5.410052wk High1.37P/B10.93MFloat Cap1.001052wk Low--Dividend TTM7.75MShs Float51.5000Historical High--Div YieldTTM31.19%Amplitude1.0010Historical Low1.3100Avg Price1Lot Size
Alterity Therapeutics Stock Forum
📊⚡️📊
11/10/2024 - 19:35
MELBOURNE, Australia and SAN FRANCISCO, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced promising new data related to ATH434 were presented a...
No comment yet